title: Duel over discounts. Pharma, providers at odds over 'orphan drugs'.
authors.forename: Rich
authors.initials: R
authors.lastname: Daly
mesh_terms: D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D017850:Economics, Pharmaceutical / Q000592:standards* / Q000639:trends; D006801:Humans; D009965:Orphan Drug Production / Q000191:economics* / Q000706:statistics & numerical data; D035583:Rare Diseases / Q000188:drug therapy / Q000191:economics*; D012052:Reimbursement, Incentive / Q000592:standards* / Q000639:trends; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards